适用于治疗激素受体 (HR) 阳性、人类表皮生长因子受体 2 (HER2) 阴性的晚期或转移性乳腺癌的成年患者
相关产品
¥2,015.00
≈ ₭6,246,500
≈ ₭6,246,500
0 out of 5
¥515.00
≈ ₭1,596,500
≈ ₭1,596,500
0 out of 5
¥639.52
≈ ₭1,982,500
≈ ₭1,982,500
0 out of 5
¥2,715.00
≈ ₭8,416,500
≈ ₭8,416,500
0 out of 5
¥1,328.23
≈ ₭4,117,500
≈ ₭4,117,500
0 out of 5
¥1,215.00
≈ ₭3,766,500
≈ ₭3,766,500
0 out of 5
¥196.77
≈ ¥196.77
≈ ₭610,000 – ₭1,830,000价格范围:₭610,000 至 ₭1,830,000
≈ ¥196.77
≈ ₭610,000 – ₭1,830,000价格范围:₭610,000 至 ₭1,830,000
0 out of 5
¥215.00
≈ ₭666,500
≈ ₭666,500
0 out of 5















评价
目前还没有评价